Alpha DNA Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPG Industries
PPG
|
+$3M |
| 2 |
TE Connectivity
TEL
|
+$2.05M |
| 3 |
NextEra Energy
NEE
|
+$1.96M |
| 4 |
Coca-Cola
KO
|
+$1.89M |
| 5 |
Merck
MRK
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$2.79M |
| 2 |
Mondelez International
MDLZ
|
+$2.26M |
| 3 |
Walmart Inc
WMT
|
+$2.23M |
| 4 |
Becton Dickinson
BDX
|
+$2.05M |
| 5 |
Blackrock
BLK
|
+$1.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.46% |
| 2 | Healthcare | 12.06% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 7.3% |
| 5 | Consumer Staples | 4.26% |
Similar funds
Alpha DNA Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Alpha DNA Investment Management held 226 positions worth $300M, down 11% from $339M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Alpha DNA Investment Management withdrew a net $58.8M in Q2 2023, closing 79 positions and reducing 41 holdings. Its most notable exit was Becton Dickinson, an estimated $2.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Alpha DNA Investment Management opened a new position in TE Connectivity worth $2.27M.
- Alpha DNA Investment Management's largest Q2 2023 buy was TE Connectivity: 16,223 shares worth $2.27M.
- Alpha DNA Investment Management added most to PPG Industries in Q2 2023, an estimated $3M increase.
- Alpha DNA Investment Management's biggest Q2 2023 reduction was PepsiCo, cutting an estimated $2.79M.
- Alpha DNA Investment Management fully exited Becton Dickinson in Q2 2023, selling an estimated $2.05M.
- Alpha DNA Investment Management's ten largest holdings make up 52% of its $300M portfolio in Q2 2023.
- Alpha DNA Investment Management opened 79 new positions and closed 79 in Q2 2023.
- Alpha DNA Investment Management's portfolio value fell 11% quarter-over-quarter to $300M.
Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.